Page last updated: 2024-08-23

raloxifene hydrochloride and Carcinoma, Ductal, Breast

raloxifene hydrochloride has been researched along with Carcinoma, Ductal, Breast in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (6.25)	18.2507
2000's	9 (56.25)	29.6817
2010's	6 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Vogel, VG	1
Mershon, JL; Mitchell, B; Qu, Y; Vogel, VG; Wong, M	1
Cutuli, B; Kerbrat, P; Lesur, A; Namer, M	1
da Silva, BB; dos Santos, AR; Lopes-Costa, PV; Pires, CG	1
da Silva, BB; dos Santos, AR; dos Santos, LG; Lopes-Costa, PV	1
Kane, RL; Shamilyan, T; Tuttle, TM; Virnig, BA; Wang, SY	1
Clarfeld, RB; Costantino, JP; Grant, MD; McCaskill-Stevens, W; Vogel, VG; Wickerham, DL; Wolmark, N	1
da Silva, BB; dos Santos, LG	1
da Silva, BB; dos Santos, AR; Lopes-Costa, PV	1
Belli, AK; Buckley, JM; Coopey, SB; Gadd, MA; Garber, JE; Guidi, AJ; Hughes, KS; Kim, EM; Mazzola, E; Parmigiani, G; Polubriaginof, F; Roche, CA; Sharko, J; Smith, BL; Specht, MC	1
Fabris, V; Helguero, LA; Lamb, CA; Lanari, C; Lucas, C; Molinolo, AA	1
Eng-Wong, J; Faupel-Badger, JM; Prindiville, SA; Venzon, D; Vonderhaar, BK; Zujewski, JA	1
Anderson, GL; Bernstein, L; Bondy, M; Costantino, JP; Gail, MH; Malone, KE; Marchbanks, PA; McCaskill-Stevens, W; Newman, L; Norman, SA; Pee, D; Selvan, M; Simon, MS; Spirtas, R; Ursin, G	1
Burshell, AL; Cauley, JA; Delmas, PD; Dowsett, SA; Mershon, JL; Secrest, RJ; Song, J	1

Reviews

4 review(s) available for raloxifene hydrochloride and Carcinoma, Ductal, Breast

Article	Year
Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene. Clinical interventions in aging, 2008, Volume: 3, Issue:4 Topics: Adult; Aged; Bone Density Conservation Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators	2008
[Breast cancer chemoprevention. Rational, trials results and future]. Bulletin du cancer, 2009, Volume: 96, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Family Health; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen	2009
Ductal carcinoma in situ: risk factors and impact of screening. Journal of the National Cancer Institute. Monographs, 2010, Volume: 2010, Issue:41 Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Chemoprevention; Female; Hormone Replacement Therapy; Humans; Incidence; Mammography; Mass Screening; Middle Aged; Multicenter Studies as Topic; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Tamoxifen; Young Adult	2010
Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials. Journal of the National Cancer Institute. Monographs, 2010, Volume: 2010, Issue:41 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Chemoprevention; Clinical Trials as Topic; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hyperplasia; Incidence; Multicenter Studies as Topic; Pulmonary Embolism; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome	2010

Trials

3 trial(s) available for raloxifene hydrochloride and Carcinoma, Ductal, Breast

Article	Year
Incidence of invasive breast cancer in postmenopausal women after discontinuation of long-term raloxifene administration. Clinical breast cancer, 2009, Volume: 9, Issue:1 Topics: Aged, 80 and over; Bone Density Conservation Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Double-Blind Method; Female; Humans; Incidence; Prognosis; Raloxifene Hydrochloride; Survival Rate; Treatment Outcome	2009
Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, Volume: 15, Issue:6 Topics: Adult; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Estradiol; Female; Humans; Middle Aged; Neoplasm Invasiveness; Pilot Projects; Premenopause; Prolactin; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin	2006
Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis. Current medical research and opinion, 2008, Volume: 24, Issue:3 Topics: Aged; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Femur; Follow-Up Studies; Humans; Incidence; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Receptors, Estrogen; Risk Factors; Selective Estrogen Receptor Modulators; United States	2008

Other Studies

9 other study(ies) available for raloxifene hydrochloride and Carcinoma, Ductal, Breast

Article	Year
Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women. Cell proliferation, 2009, Volume: 42, Issue:4 Topics: Aged; Carcinoma, Ductal, Breast; Estrogen Antagonists; Female; Humans; Immunohistochemistry; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Vascular Endothelial Growth Factor A	2009
Evaluation of Ki-67 and Bcl-2 antigen expression in breast carcinomas of women treated with raloxifene. Cell proliferation, 2010, Volume: 43, Issue:2 Topics: Aged; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Nucleus; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators	2010
The effect of raloxifene on telomerase expression in breast carcinoma samples from postmenopausal women. European journal of obstetrics, gynecology, and reproductive biology, 2011, Volume: 159, Issue:1 Topics: Aged; Antineoplastic Agents; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Down-Regulation; Female; Humans; Immunohistochemistry; Mammary Glands, Human; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Postmenopause; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Telomerase	2011
The effect of raloxifene on Bax protein expression in breast carcinomas of postmenopausal women. Diagnostic cytopathology, 2012, Volume: 40, Issue:7 Topics: Aged; bcl-2-Associated X Protein; Biomarkers, Tumor; Biopsy; Carcinoma, Ductal, Breast; Female; Humans; Immunohistochemistry; Middle Aged; Neoplasm Staging; Postmenopause; Prognosis; Raloxifene Hydrochloride; Receptors, Estrogen; Treatment Outcome	2012
The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast cancer research and treatment, 2012, Volume: 136, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Anticarcinogenic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemoprevention; Female; Humans; Hyperplasia; Mammary Glands, Human; Middle Aged; Precancerous Conditions; Raloxifene Hydrochloride; Tamoxifen	2012
Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma. Breast cancer research and treatment, 2003, Volume: 79, Issue:1 Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Estrogen Receptor Modulators; Female; Medroxyprogesterone Acetate; Melitten; Mice; Mice, Inbred BALB C; Raloxifene Hydrochloride; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured	2003
STAR trial reports. European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:12 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Estrogen Antagonists; Female; Humans; Multicenter Studies as Topic; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Tamoxifen	2006
Projecting individualized absolute invasive breast cancer risk in African American women. Journal of the National Cancer Institute, 2007, Dec-05, Volume: 99, Issue:23 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Biopsy; Black or African American; Breast Neoplasms; Carcinoma, Ductal, Breast; Confounding Factors, Epidemiologic; Estrogen Receptor Modulators; Female; Forecasting; Humans; Incidence; Logistic Models; Mammography; Mass Screening; Middle Aged; Odds Ratio; Raloxifene Hydrochloride; Risk Assessment; SEER Program; Tamoxifen; United States; Women's Health	2007
Designer estrogens: breast cancer benefit, remaining questions. Health news (Waltham, Mass.), 1999, Jul-25, Volume: 5, Issue:9 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Estrogen Antagonists; Female; Humans; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Tamoxifen	1999